More of the same. Esopus sees one term value well beyond the $208M going to Pharmathene. Doesn't want any special deals worked out to make Pharmathene satisfied at their expense. Esopus does realize they invested in a Chapter 11 Company with many years of court testimony showing bad faith in a roll the dice and gamble on the part of Siga. The $113M plus interest should have been much more favorable to Pharmathene. Siga is coming out way ahead of where the contract would have put them.
Sad day for Pharmathene shareholders when seeing $208M was the final amount the court calculated as a just award.
Again, Esopus the court papers were public knowledge, past rulings public knowledge, bad faith tendency of Siga management were well known. Esopus management rolled the dice and hoped for a big payoff and it didn't happen. Somebody should now be suing Esopus for reckless gambling with investors money.
After litigation is over I'm thinking liquidation will eventually be end game for Pharmathene, leads to increased payout to PIP shareholders. This card not to be played until after Chapter 11 negotiations are over and signed contract is in place. If we wind up with some preferred shares I think the payout will also be larger.
Who dat selling at $2.07? Congrats on what are likely huge percentage gains. I do understand but think they are leaving more big percentage games on the table.
No offense taken.
Looks to me like everyone is working together to make this chapter 11 exit as profitable as possible for Pharmathene and Siga "Insider Family Members". Chapter 11 status could have been the worst move Siga shareholders could have possibly hoped for.
Where did all those bashers, the non-binding and too speculative group, go? There are the Tee attackers, guess that would be the bitter ones who I hope have learned a lesson. Honestly, I got out of Siga in Sept 2006 when I saw white collar theft at work. Why would anyone invest in a company that has no regard for corporate responsibilities and ethics. Day traders and swing traders I suspect.
This stage of Chapter 11, specifically for Siga shareholders, is no place I would even put my gambling money.
Roll up and gouge doesn't always work for Wall Street. Bet there are plenty of Wall Street people still putting millions into their personal accounts as they lose other people's money in VRX.
Doc 856 page 6
8. By this Motion, the Debtor requests, pursuant to section 1121(d) of the Bankruptcy Code, a further thirty (30) day extension of the Exclusive Solicitation Period through and including May 16, 2016. If the Plan is confirmed and becomes effective before the Exclusive Solicitation Period expires, the Debtor shall withdraw this Motion.
* lots of info in this one be sure to read all 15 pages. Please share your thoughts if you see anything new to case and/or implications. Sumpan's up is my guess.
further extending the Debtor’s exclusive period during which only the Debtor may propose a plan and only solicitation of acceptances or rejections with respect to the plan proposed and filed by the Debtor may occur
non-inferiority trial designed to show efficacy and improved S.E. profile will likely be needed. Merck dropped out their Bextriban partnership for a reason?
Ronny P is all about the dollar. Playing nice and cooperating is now the only way to get the most out of this deal.
Volume up, price up and increasing angst among institutions wanting to participate in the upside of Siga post Pharmathene settlement. Reading my tea leaves....
It's Chapter 11 and the big boys knew the facts that were out there in 2006. That would be the year I sold my Siga shares.
"The Chapter 11 reorganization plan has to be approved by the company's creditors and the bankruptcy court. Shareholders typically aren't guaranteed a say in the process, and they usually don't get one. According to the Securities and Exchange Commission, in most Chapter 11 cases, the final reorganization plan will cancel the company's existing stock. If that happens, then all outstanding shares become worthless. If the company issues new stock, the previous shareholders may get new shares -- or all the new shares might go to the creditors. Even in cases where the existing stock remains valid, the company may issue more shares as compensation to the creditors, substantially diluting the value of existing shares."
* Piper Jaffray operates principally through four business segments:
Mergers and acquisitions advisory
Public equity offerings
Debt and equity offerings
* Suppose the two companies are working on a plan that maximizes the ROI. Do you let Siga pay taxes on profits and than hand that money to Pharmathene and let them pay taxes on the profits? Wild guess, NO. Everyone works together and splits an additional $50M (wild guess) as a ROI because at this point it is time to focus on ROI. The court games are litteraly over and everyone is here to make money. Piper will be well paid to work out the most profitable exit to the soon to be ended Chapter 11 overseen Supreme Court decided case.
Rite Aid and Walgreens are merging at $9.00. Big well known and trusted institutions w/o the nasty unending bad faith to price into such a risk arbitrage.
RAD trades at $7.60 to $8.00
PIP trades at $1.73 with a much larger percentage risk arbitrage discount.
As shorts see Piper doing their job of getting a large valuation for -246 a bad rumor needs to be floated to get those boyz out of that short position. What kind of idiot small trader would short a $1.70 stock?
SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX, milestone payment also comes with liquid formulation. (March 17 headline.
Over $50M if the tablet formulation is considered potent at 5 (?) years. The unable to pay the $208M talk is being replaced by potential eventual valuation of -246. Piper is performing their magic.
Chapter 11. Means Piper"s first obligation is looking out for debt holders (Pharmathene). Good sign they have brought them in now, two parties must be in agreement on what they want in their Chapter 11 exit . Piper knows the tricks of the trades to accomplish what the credit holders want. Piper's second obligation is to do what is needed to keep Siga alive and functional to fulfill current contracts and milestones.
Siga will be paying Piper steep fees at this point, maybe in shares.
Holders of current Siga shares, chapter 11 is not a good place to be. Just my wild guess
large cash payment upfront plus preferred shares of new Siga shares issued to PIP shareholders and an overall deal that eliminates double taxation while taking full advantage of NOLs on both sides. It's going to be all about ROI now that Piper specialists are looking at this.